Cancer-killing cells
AssigneeLIfT BioSciences Ltd
InventorsAlex Blyth, Nico Bruyniks
Life of this patent
Estimating the term…
Abstract
The present invention relates to an in vitro culture of haematopoietic cells, wherein said haematopoietic cells differentiate to form granulocytes characterised by the ability to kill cancer cells. The invention also relates to said granulocytes, methods for identifying said haematopoietic cells and granulocytes, compositions and kits comprising the same, as well as uses of the same for treating cancer.
Claims18
A method of treating cancer in a subject in need thereof comprising administering a formulation to the subject in need thereof thereby treating cancer in the subject in need thereof, wherein the formulation comprises hematopoietic cells derived from a donor that produces granulocytes with the ability to kill cancer cells.
A method of treating cancer in a subject in need thereof comprising administering a formulation to the subject in need thereof thereby treating cancer in the subject in need thereof, wherein the formulation comprises granulocytes, granulocyte precursor cells, or combinations thereof wherein the granulocytes, granulocyte precursor cells, or combinations thereof are differentiated ex vivo from hematopoietic cells derived from a donor that produces granulocytes with the ability to kill cancer cells.
Dependencies are inferred from the claim text.